Click Therapeutics
Click Therapeutics is a pioneering company developing, validating, and commercializing software as prescription medical treatments for people with unmet medical needs. Their business model focuses on prescription digital therapeutics (PDTs) that combine neuroscience and software to create new modalities of medicine, including Software-Enhanced Drugs™ that integrate software with pharmacotherapy for enhanced clinical benefits. The company operates a leading AI-enabled prescription digital therapeutics platform and collaborates with pharmaceutical partners like Otsuka. Their products target conditions such as major depressive disorder, episodic migraine, schizophrenia, and type 2 diabetes, with FDA clearances and ongoing pivotal trials. Supported by biotech and pharma investors, Click Therapeutics is positioned at the intersection of biology and technology, aiming to transform patient care and expand access to digital treatments globally.
Click Therapeutics
Click Therapeutics is a pioneering company developing, validating, and commercializing software as prescription medical treatments for people with unmet medical needs. Their business model focuses on prescription digital therapeutics (PDTs) that combine neuroscience and software to create new modalities of medicine, including Software-Enhanced Drugs™ that integrate software with pharmacotherapy for enhanced clinical benefits. The company operates a leading AI-enabled prescription digital therapeutics platform and collaborates with pharmaceutical partners like Otsuka. Their products target conditions such as major depressive disorder, episodic migraine, schizophrenia, and type 2 diabetes, with FDA clearances and ongoing pivotal trials. Supported by biotech and pharma investors, Click Therapeutics is positioned at the intersection of biology and technology, aiming to transform patient care and expand access to digital treatments globally.